Page 2073 - Hematology_ Basic Principles and Practice ( PDFDrive )

1842 Part XII Hemostasis and Thrombosis

REFERENCES 16. Woodruff RS, Sullenger B, Becker RC: The many faces of the contact
pathway and their role in thrombosis. J Thromb Thrombolysis 32(1):9–20,
1. Lippi G, Franchini M, Targher G: Arterial thrombus formation in 2011.
cardiovascular disease. Nat Rev Cardiol 8:502, 2011. 17. Fager AM, Wood JP, Bouchard BA, et al: Properties of procoagulant
2. Reitsma PH, Versteeg HH, Middledorp S: Mechanistic view of risk platelets: defining and characterizing the subpopulation binding a func-
factors for venous thromboembolism. Arterioscler Thromb Vasc Biol tional prothrombinase. Arterioscler Thromb Vasc Biol 30(12):2400–2407,
32(3):563–568, 2012. 2010.
3. Morris TA: Natural history of venous thromboembolism. Crit Care Clin 18. Lord ST: Molecular mechanisms affecting fibrin structure and stability.
27(4):869–884, 2011. Arterioscler Thromb Vasc Biol 31(3):494–499, 2011.
4. van Hinsbergh VW: Endothelium – role in regulation and coagulation 19. Wolberg AS: Plasma and cellular contributions to fibrin network forma-
and inflammation. Semin Immunopathol 34(1):93–106, 2012. tion, structure and stability. Haemophilia 16(Suppl 3):7–12, 2010.
5. Wood JP, Ellery PE, Maroney SA, et al: Biology of tissue factor pathway 20. Schaller J, Gerber SS: The plasmin-antiplasmin system: structural and
inhibitor. Blood 123(19):2934–2943, 2014. functional aspects. Cell Mol Life Sci 68(5):785–801, 2011.
6. Esmon CT: Protein C anticoagulant system–anti-inflammatory effects. 21. Heylen E, Willemse J, Hendriks D: An update on the role of car-
Semin Immunopathol 34(1):127–132, 2012. boxypeptidase U (TAFIa) in fibrinolysis. Front Biosci 17:2427–2450,
7. Nieswandt B, Pleines I, Bender M: Platelet adhesion and activation 2011.
mechanisms in arterial thrombosis and ischaemic stroke. J Thromb 22. Broos K, Feys HB, DeMeyer SF, et al: Platelets at work in primary
Haemost 9(Suppl 1):92–104, 2011. hemostasis. Blood Rev 25(4):155–167, 2011.
8. Di Stasio E, De Cristofaro R: The effect of shear stress on protein 23. Eby C: Pathogenesis and management of bleeding and thrombosis in
conformation: physical forces operating on biochemical systems: the case plasma cell dyscrasias. Br J Haematol 145(2):151–163, 2009.
of von Willebrand factor. Biophys Chem 153(1):1–8, 2010. 24. Malfait F, DePaepe A: Bleeding in the heritable connective tissue disor-
9. Hechler B, Gachet C: P2 receptors and platelet function. Purinergic ders: mechanisms, diagnosis and treatment. Blood Rev 23(5):191–197,
Signal 7(3):293–303, 2011. 2009.
10. Alberelli MA, De Candia E: Functional role of protease activated recep- 25. Komaromi I, Bagoly Z, Muszbek L: Factor XIII: novel structural and
tors in vascular biology. Vascul Pharmacol 62(2):72–81, 2014. functional aspects. J Thromb Haemost 9(1):9–20, 2011.
11. Bennett JS, Moore DT: Regulation of platelet beta 3 integrins. Haema- 26. Borissoff JI, Spronk HM, ten Cate H: The hemostatic system as a
tologica 95(7):1049–1051, 2010. modulator of atherosclerosis. N Engl J Med 364(18):1746–1760,
12. Versteeg HH, Heemskerk JW, Levi M, et al: New fundamentals in 2011.
hemostasis. Physiol Rev 93(1):327–358, 2013. 27. Watson T, Shantsila E, Lip GY: Mechanisms of thrombogenesis in atrial
13. Mann KG: Thrombin generation in hemorrhage control and vascular fibrillation: Virchow’s triad revisited. Lancet 373(9658):155–166, 2009.
occlusion. Circulation 124(2):225–235, 2011. 28. Tchaikovski SN, Rosing J: Mechanisms of estrogen-induced venous
14. Rao LV, Pendurthi UR: Regulation of tissue factor coagulant activity on thromboembolism. Thromb Res 126(1):5–11, 2010.
cell surfaces. J Thromb Haemost 10(11):2242–2253, 2012. 29. Anderson JA, Weitz JI: Hypercoagulable states. Crit Care Clin
15. Ahmad SS, London FS, Walsh PN: The assembly of the factor X-activating 27(4):933–952, 2011.
complex on activated human platelets. J Thromb Haemost 1(1):48–59,
2003.